ConductScience.org, home

Paper14872002

Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa.

Wozniak DJ and 1 other. Chest, 2004. Cited by 121 papers, by iCite.

Cite this record

ConductScience Library. Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Papers, record 14872002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14872002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa.
PubMed
Journal
Chest
PubMed
Year
2004
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
121
iCite
Relative citation ratio, by iCite
3.73
iCite
Revised in PubMed
2019-05-14
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wozniak DJDaniel J
2Keyser RRebecca

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
BiofilmsMajor topic
Pseudomonas aeruginosaMajor topic
Humans
Microbial Sensitivity Tests

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 121 citations.

PMIDTitleJournalYearIn PapersSource
42931160Proteomic Insights into Antibiotic Resistance and Biofilm Adaptation of Staphylococcus epidermidis to Subinhibitory Levofloxacin, Rifampicin, and Combination Treatment.Pathogens2026https://conductscience.org/library/papers/42931160PubMed
41271585Cinnamic-Hydroxamic-Acid Derivatives Exhibit Antibiotic, Anti-Biofilm, and Supercoiling Relaxation Properties by Targeting Bacterial Nucleoid-Associated Protein HU.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41271585PubMed
39469629Subinhibitory concentrations of antibiotics affect development and parameters of Helicobacter pylori biofilm.Front Pharmacol2024https://conductscience.org/library/papers/39469629PubMed
36830100Macrolides at Clinically-Relevant Concentrations May Induce Biofilm Formation in Macrolide-Resistant Staphylococcus aureus.Antibiotics (Basel)2023https://conductscience.org/library/papers/36830100PubMed
36409005
Azithromycin use prior to ICU admission is associated with a lower short-term mortality for critically ill acute exacerbations of chronic obstructive pulmonary disease patients: A retrospective cohort study.
Chron Respir Dis2022https://conductscience.org/library/papers/36409005PubMed
36318447The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection.Vet Med Sci2023https://conductscience.org/library/papers/36318447PubMed
35052954Innovative Perspectives on Biofilm Interactions in Poultry Drinking Water Systems and Veterinary Antibiotics Used Worldwide.Antibiotics (Basel)2022https://conductscience.org/library/papers/35052954PubMed
35024736Adenoidal bacterial biofilm in pediatric rhinosinusitis.Rom J Morphol Embryol2021https://conductscience.org/library/papers/35024736PubMed
34733256Impacts of Ser/Thr Protein Kinase Stk1 on the Proteome, Twitching Motility, and Competitive Advantage in Pseudomonas aeruginosa.Front Microbiol2021https://conductscience.org/library/papers/34733256PubMed
34729086Maximum levels of cross-contamination for 24 antimicrobial active substances in non-target feed. Part 6: Macrolides: tilmicosin, tylosin and tylvalosin.EFSA J2021https://conductscience.org/library/papers/34729086PubMed
34578219Oxidative Stress Response in Pseudomonas aeruginosa.Pathogens2021https://conductscience.org/library/papers/34578219PubMed
34362401Quinic acid: a potential antibiofilm agent against clinical resistant Pseudomonas aeruginosa.Chin Med2021https://conductscience.org/library/papers/34362401PubMed
34206280Dynamic Adaptive Response of Pseudomonas aeruginosa to Clindamycin/Rifampicin-Impregnated Catheters.Antibiotics (Basel)2021https://conductscience.org/library/papers/34206280PubMed
33806815Antibiotics as a Stressing Factor Triggering the Harboring of Helicobacter pylori J99 within Candida albicans ATCC10231.Pathogens2021https://conductscience.org/library/papers/33806815PubMed
32932703The Anti-Pseudomonal Peptide D-BMAP18 Is Active in Cystic Fibrosis Sputum and Displays Anti-Inflammatory In Vitro Activity.Microorganisms2020https://conductscience.org/library/papers/32932703PubMed
31998248Clinical Impact of Antibiotics for the Treatment of Pseudomonas aeruginosa Biofilm Infections.Front Microbiol2019https://conductscience.org/library/papers/31998248PubMed
31490973Methyl gallate and tylosin synergistically reduce the membrane integrity and intracellular survival of Salmonella Typhimurium.PLoS One2019https://conductscience.org/library/papers/31490973PubMed
30663791
Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study.
Pharmacotherapy2019https://conductscience.org/library/papers/30663791PubMed
28894437Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study.Front Microbiol2017https://conductscience.org/library/papers/28894437PubMed
28714611Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.Pediatr Pulmonol2017https://conductscience.org/library/papers/28714611PubMed

See all 51 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14872002

GET https://conductscience.org/api/papers/v1/14872002/cited_by?page=2